Intervention not reported
- Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine 2013 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 2213 participantsGRADE not reported
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether fluoroquinolones changes other adverse events clinical criteria compared with beta‐lactams (very low certainty).
It is very uncertain whether fluoroquinolones changes other adverse events clinical criteria compared with macrolides (very low certainty).
It is very uncertain whether cotrimoxazole changes other adverse events clinical criteria compared with beta‐lactams (very low certainty).
It is very uncertain whether cotrimoxazole changes other adverse events clinical criteria compared with fluoroquinolones (norfloxacin) (very low certainty).
It is very uncertain whether antibiotic changes other adverse events clinical criteria compared with no drug or placebo (very low certainty).